Unique ID issued by UMIN | UMIN000053415 |
---|---|
Receipt number | R000060965 |
Scientific Title | Efficacy and Safety of Endoscopic Tumor Resection Applying Pre-Removal Drawstring Suture for Gastrointestinal Tumors |
Date of disclosure of the study information | 2024/01/23 |
Last modified on | 2025/02/25 07:30:39 |
Efficacy and Safety of Endoscopic Tumor Resection Applying Pre-Removal Drawstring Suture for Gastrointestinal Tumors
ESR study
Efficacy and Safety of Endoscopic Tumor Resection Applying Pre-Removal Drawstring Suture for Gastrointestinal Tumors
ESR study
Japan |
gastrointestinal tumor
Gastroenterology |
Malignancy
NO
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are widely used in the treatment of gastrointestinal tumors. Although advances in technology and equipment have improved the safety of treatment, there are still challenging cases, and bleeding, perforation, and other complications have been observed. In recent years, the development of a needle holder for use with a flexible endoscope has made it possible to suture endoscopically, and manual suturing of the ulcer bottom after ESD has become possible for the purpose of preventing accidents, and the usefulness of this technique has been reported. In this study, we focused on the use of a width suture and devised a method that has advantages both during and after resection by suturing around the lesion before resection, and we will examine the usefulness and safety of this treatment method.
Safety,Efficacy
Treatment Completion Rate
Treatment time, batch resection rate, local fluid usage, suture retention rate, and frequency of incidentalities
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
For gastrointestinal tumors for which endoscopic submucosal dissection is indicated, we have developed a procedure in which the surrounding area is sutured prior to resection.
20 | years-old | < |
Not applicable |
Male and Female
Eligible patients must be patients who are eligible for insurance coverage of endoscopic submucosal dissection between May 2023 and May 2024, and who have received a full explanation of their participation in this study, and who have given their free and voluntary consent to the new method of treatment based on full understanding of the patient's needs.
Exclusion criteria include suspected disseminated intravascular coagulation syndrome, severe heart failure, active thromboembolism at the time of study entry, severe respiratory failure, pregnancy or women of childbearing potential, and other subjects deemed unsuitable by the study investigator (subinvestigator).
15
1st name | Takuma |
Middle name | |
Last name | Okamura |
Nagasaki harbor medical center
gastroenterology
850-8555
6-39 Shinchi-cho, Nagasaki City, Nagasaki
0958223251
taku.okamu1002@gmail.com
1st name | Takuma |
Middle name | |
Last name | Okamura |
Nagasaki Harbor Medical Center
gastroenterology
850-8555
6-39 Shinchi-cho, Nagasaki City, Nagasaki
0958223251
taku.okamu1002@gmail.com
Nagasaki harbor medical center
none
Other
Nagasaki Minato Medical Center Research and Development Center
6-39 Shinchi-cho, Nagasaki City, Nagasaki
0958223251
kenkyu@ncho.jp
NO
2024 | Year | 01 | Month | 23 | Day |
Unpublished
13
Completed
2023 | Year | 03 | Month | 01 | Day |
2023 | Year | 03 | Month | 30 | Day |
2023 | Year | 05 | Month | 01 | Day |
2028 | Year | 05 | Month | 01 | Day |
2024 | Year | 01 | Month | 23 | Day |
2025 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060965